Evaluation of the usefulness of indomethacin as supportive therapy in women with preterm labor at risk of intraamniotic inflammation [Evaluación de la utilidad de la indometacina como tratamiento de soporte en mujeres con amenaza de parto pretérmino y alto riesgo de inflamación intraamniótica].
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Indometacin (Primary)
- Indications Preterm labour
- Focus Therapeutic Use
- Acronyms INDOGEST
- 21 Oct 2014 Biomarkers information updated
- 05 Oct 2013 Planned End Date changed from 1 Apr 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 05 Jul 2012 Additional lead trial investigator (Montse Palacio) identified as reported by ClinicalTrials.gov.